Trials / Recruiting
RecruitingNCT06309979
A Study to Assess Growth in Children With Idiopathic Short Stature
A Multicenter, Observational Study to Characterize Growth in Children With Idiopathic Short Stature
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- BioMarin Pharmaceutical · Industry
- Sex
- All
- Age
- 2 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.
Conditions
Timeline
- Start date
- 2024-08-08
- Primary completion
- 2040-12-31
- Completion
- 2040-12-31
- First posted
- 2024-03-13
- Last updated
- 2025-11-14
Locations
40 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06309979. Inclusion in this directory is not an endorsement.